Abel Torres » Department of Dermatology » College of Medicine

About Abel Torres

Dr. Torres is a clinician, researcher, educator and lawyer serving as chair of the University of Florida Department of Dermatology. He has Board Certification in Internal Medicine and Dermatology and Bar/Law License Certification and has devoted his career to tackling complex dermatologic conditions, providing excellent patient care, embarking on extensive research and training medical students, residents and fellows in both the clinical, surgical and legal areas of medicine.

He has led research on topics including the treatment of leg ulcers and burns, precancerous lesions such as actinic keratosis and skin cancer. Dr. Torres’ current research interests include establishing the role of topical immunomodulators in the treatment of skin cancers, as well as noninvasive techniques in skin cancer detection and surgery.

Dr. Torres completed an advanced International Dermatologic Surgery Fellowship at the University of Seville, Spain and a Dermatologic Surgery at the University of California at San Francisco where he received intensive training in Skin Cancer Surgery including Mohs Surgery and Reconstruction and Cosmetic Dermatologic Surgery. His Cosmetic Surgery training includes lasers, liposuction surgery, fillers, neuromodulators/Botox, micro and macrodermabrasion, microneedling, Platelet Rich Plasma (PRP), chemical peeling and more. He has since directed fellowship training programs training dermatologists and post training fellows at the Brigham and Woman’s Hospital/Harvard Medical School, Loma Linda University, Case Western Reserve University/MetroHealth Systems and most recently at the University of Florida Gainesville.

Accomplishments

Chairman & Professor of Dermatology

2018-Current University of Florida, College of Medicine
President of the American Academy of Dermatology

2016-2017 American Academy of Dermatology
Treasurer

2012-2015 American Society for Dermatologic Surgery Board
Member of the Board of Directors, American Academy of Dermatology

2011-2014 American Academy of Dermatology
Member of the Board of Directors, American Society for Dermatologic Surgery

2009-2012 American Society for Dermatologic Surgery

Board Certifications

Dermatology

American Board of Dermatology
Mohs Fellowship Certificate

American College of Mohs Micrographic Surgery and Cutaneous Oncology

Clinical Profile

Specialties

Dermatology

Areas of Interest

Actinic Keratosis
Burns
Mohs Micrographic Surgery
Skin Cancer

Publications

Academic Articles

Patient satisfaction with teledermatology: A systematic review and meta-analysis.
2024

Journal

Journal of the American Academy of Dermatology.

Volume/Issue

91(6):1288-1289

[DOI]

10.1016/j.jaad.2024.07.1526.

[PMID]

39218356.

PubMed Publisher’s Site
Reducing Legal Risks and Social Media Issues for Cosmetic Surgery.
2023

Journal

Facial plastic surgery clinics of North America.

Volume/Issue

31(2):333-340

[DOI]

10.1016/j.fsc.2023.01.017.

[PMID]

37001936.

4 citations PubMed Publisher’s Site
A Retrospective Review of Histopathologic Features Associated with Increased Risk of Recurrence of Non-melanoma Skin Cancer After Mohs Micrographic Surgery.
2022

Journal

The Journal of clinical and aesthetic dermatology.

Volume/Issue

15(1):27-29

[PMID]

35309269.

PubMed
Leukemia cutis mimicking tumid lupus as the presenting sign in a case of mixed T/B-cell acute lymphoblastic leukemia.
2020

Journal

JAAD case reports.

Volume/Issue

6(7):598-602

[DOI]

10.1016/j.jdcr.2020.04.033.

[PMID]

32685647.

4 citations PubMed Publisher’s Site
Dermatology leadership and a top-down approach to increasing diversity.
2020

Journal

Clinics in dermatology.

Volume/Issue

38(3):316-320

[DOI]

10.1016/j.clindermatol.2020.02.006.

[PMID]

32563343.

8 citations PubMed Publisher’s Site
Practicing Safe Dermatology-Screening Out Liability.
2018

Journal

JAMA dermatology.

Volume/Issue

154(2):142-143

[DOI]

10.1001/jamadermatol.2017.4838.

[PMID]

29214301.

PubMed Publisher’s Site
Commentary on Signs of Facial Aging in Men in a Diverse, Multinational Study: Timing and Preventive Behaviors.
2017

Journal

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Volume/Issue

43 Suppl 2:S221-S224

[DOI]

10.1097/DSS.0000000000001379.

[PMID]

29064989.

1 citation PubMed Publisher’s Site

Grants

Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in when used in Combination with Topical Corticosteroid Treatment in Patients with Moderate-to-Severe Atopic Dermatitis

October 12, 2020 – February 3, 2022

Role:

Principal Investigator

Funding:

SYNEOS HEALTH via DERMIRA
A randomized, double-blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz) and BF-RhodoLED in the treatment of superficial basal cell carcinoma with photodynamic therapy

September 10, 2018 Active

Role:

Principal Investigator

Funding:

BIOFRONTERA BIOSCIENCE GMBH

Education

MBA

2014-2016 Weatherland School of Management, Case Western Reserve University
J.D.

1987-1991 Loyola Marymount University Law School
Medical Degree

1977-1979 Mount Sinai School of Medicine, CUNY
Bachelor of Science – Biomedical Sciences

1973-1977 Sophie Davis Center for Biomedical Education, CUNY